MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The phenotypic spectrum of patients with progressive supranuclear palsy

M. Gultekin, R. Baydemir, M.F. Gol, M. Mirza (Kayseri, Turkey)

Meeting: 2017 International Congress

Abstract Number: 207

Keywords: Parkinsonism, Progressive supranuclear palsy(PSP)

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: The aim of the this study to evaluate different modes of (initial) clinic type of patients with PSP.

Background: Progressive supranuclear palsy (PSP) is a sporadic, adult-onset tauopathy with one of an Parkinson-plus syndromes. PSP has different symptoms such as early postural instability with falls, supranuclear vertical gaze palsy, symmetric akinesia and rigidity. Also, it may has eight varied clinic picture in course.

Methods: Fifteen patient’s with PSP included the study. All patients evaluated according to clinical criteria for the diagnosis of PSP (NINDS-SPSP). Then,  reviewed and categorized for different types by the clinician who experienced on the movement disorders.

Results: Nine of the patients were female. The mean age of patients were 65.4. Only two patients were diagnosed PSP with initial symptoms. The other were diagnosed idiopatic Parkinson’s disease by the neurologist. The patients were reviewed by the clinician. Seven patients were included PSP with Richardson’s syndrome (PSP-RS) form. Three patients were included PSP with predominant parkinsonism (PSP-P) form. The other five patients were included mixt form of PSP-RS and PSP-P.

Conclusions: This study with few patients show that PSP is required to  an early and accurate diagnosis especially for the different type of clinical spectrum of PSP.

References:

  1. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996 Jul;47(1):1-9. Review.
  2. Respondek G, Höglinger GU. The phenotypic spectrum of progressive supranuclear palsy Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S34-6. doi: 10.1016/j.parkreldis.2015.09.041. Review.

To cite this abstract in AMA style:

M. Gultekin, R. Baydemir, M.F. Gol, M. Mirza. The phenotypic spectrum of patients with progressive supranuclear palsy [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/the-phenotypic-spectrum-of-patients-with-progressive-supranuclear-palsy/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-phenotypic-spectrum-of-patients-with-progressive-supranuclear-palsy/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley